North America Bariatric Surgery Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 1.05 Billion |
| Market Size (2029) | USD 1.38 Billion |
| CAGR (2024 - 2029) | 5.45 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
North America Bariatric Surgery Market Analysis
The North America Bariatric Surgery Market size is estimated at USD 1.05 billion in 2024, and is expected to reach USD 1.38 billion by 2029, growing at a CAGR of 5.45% during the forecast period (2024-2029).
Elective surgeries, including bariatric surgery, were restricted during the pandemic, and the willingness to seek medical treatment also changed. The number of patients with obesity who underwent surgery was significantly reduced. According to an article published by PubMed Central in March 2022, a study was conducted in North America, which showed that there was a 12.1% reduction in total bariatric surgery cases and a 13.8% reduction in bariatric surgery cases per center. Thus, the COVID-19 pandemic significantly impacted the market initially, however as the pandemic has currently subsided, bariatric surgery procedures are taking place normally, hence the studied market is expected to have stable growth during the forecast period of the study.
Factors such as the increase in obesity patients, the high prevalence of type-2 diabetes and heart diseases, and increasing public awareness about bariatric surgery and government initiatives to curb obesity are expected to boost the market's growth during the forecast period of the study.
The increasing prevalence of obesity is a major factor driving the growth of the market, as bariatric surgery is majorly performed on obese patients. For instance, according to the data published by Trust for America's Health in September 2022, it was estimated that nationally 41.9% of adults had obesity in the United States in 2021, out of which black adults had the highest level of adult obesity at 49.9 percent, Hispanic adults had an obesity rate of 45.6 percent, white adults had an obesity rate of 41.4 percent, Asian adults had an obesity rate of 16.1 percent, and rural parts of the country had higher rates of obesity than urban and suburban areas. Thus, the high prevalence of obesity is expected to boost the market growth.
As diabetes and cardiovascular diseases are major risk factors in obese patients, the rising prevalence of these diseases is also expected to boost market growth. For instance, according to the data published by Diabetes Canada in February 2022, it is estimated that 30% of Canadians live with diabetes or prediabetes. The source also stated that approximately 5,719,000 Canadians were living with type 1 diabetes, type 2 diagnosed diabetes, and type 2 undiagnosed diabetes in 2022, and this number is expected to reach 7,277,000 by 2032. Thus, the high prevalence of diabetes is also expected to boost the market growth.
Moreover, increasing product launches by key market players are also boosting the market growth. For instance, in May 2021, Standard Bariatrics launched its novel Titan SGS stapling technology, specifically designed for bariatric sleeve surgery. Also, the device has been cleared by the United States FDA.
Therefore, the aforementioned factors, such as the rising prevalence of obesity, the rising prevalence of diabetes and cardiovascular diseases, and the increasing product launches, are expected to boost market growth. However, the high cost of surgery is expected to impede the market growth during the forecast period of the study.
North America Bariatric Surgery Market Trends
This section covers the major market trends shaping the North American Bariatric Market according to our research experts:
Closure Device Segment is Expected to Experience Significant Growth Over the Forecast Period
Closure devices are used for reconnecting the tissues during surgical procedures and for closing incisions made by trocars. The laparoscopic port closure device successfully and safely closes the port sites in obese patients undergoing bariatric procedures and surgeries. These operations are performed with specialized instruments designed to be inserted through small incisions. Therefore, the rising number of laparoscopic gastric bypass (GBP) surgery procedures helps increase the usage of closure devices. Moreover, the rising prevalence of obesity and the rising prevalence of type 2 diabetes, and cardiovascular diseases are also expected to boost segment growth.
According to an article updated by NCBI in September 2022, laparoscopic gastric bypass surgery is considered to be one of the most popular weight loss surgeries in the United States of America. It has clear benefits over the traditional open approach in terms of cost and patient satisfaction with similar successes. Patients can expect to have approximately 60% excess weight loss and an exceptional long-term resolution of obesity-related comorbidities after laparoscopic gastric bypass. Thus, the increasing advantages of laparoscopic gastric bypass surgery are expected to boost the usage of closure devices during the forecast period of the study.
Furthermore, the rising prevalence of obesity in the region is also expected to boost the usage of closure devices for bariatric surgeries. For instance, according to the data published by Statistics Canada in August 2022, it has been estimated that around 2,398,200 (30.8%) people of age in between 18 to 34 years were overweight in 2021, and 1,727,000 (22.2%) people aged between 18 to 34 years were obese in 2021. Thus, the high prevalence of obesity in the region is also expected to boost segment growth.
Therefore, the aforementioned factors, such as the increasing advantages of laparoscopic gastric bypass surgery and the rising prevalence of obesity, are expected to boost segment growth during the forecast period of the study.
United States is Expected to Hold a Significant Market Share Over the Forecast Period
The bariatric surgery market in the United States is mainly driven by the increasing use of advanced technology in healthcare systems, increasing developments by major market players, the rising prevalence of type 2 diabetes and cardiovascular diseases, and the country's rising burden of obesity.
The increasing burden of obesity in the country is a major factor driving market growth. For instance, according to the data published by Dialogues économiques in March 2022, approximately 75% of Mexico's adult population is either obese or overweight, which makes it one of the world's leading countries in both adult and childhood obesity. Thus, the increasing burden of obesity is expected to increase bariatric surgeries as well, resulting in market growth.
Moreover, the increasing prevalence of diabetes and cardiovascular diseases is also expected to boost the market growth. For instance, according to the data updated by CDC in June 2022, it was estimated that 37.3 million people would have diabetes in the United States in 2021, which accounts for 11.3% of the United States population.
Additionally, the rising product launches by key market players are expected to boost the market growth. For instance, in June 2021, Ethicon, part of the Johnson & Johnson Medical Devices Companies, launched the ENSEAL X1 Curved Jaw Tissue Sealer for colorectal, gynecological, bariatric surgery, and thoracic procedures. Moreover, in September 2021, Olympus America launched the POWER SEAL advanced bipolar surgical energy devices to strengthen its Surgical Portfolio. The POWER SEAL devices can be used in numerous forms of surgical intervention, including bariatric surgical procedures.
Therefore, the aforementioned factors, such as the increasing product launches and the rising prevalence of obesity, are expected to boost the market growth in the country during the forecast period of the study.
North America Bariatric Surgery Industry Overview
The North American bariatric surgery market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With the rising number of obese patients, a few other smaller players are also expected to enter the market in the coming few years. Some of the major players in the market are Medtronic PLC, Ethicon Inc., Johnson and Johnson, B. Braun SE, Olympus Corporation, and Conmed Corporation, among others.
North America Bariatric Surgery Market Leaders
-
Medtronic PLC
-
Olympus Corporation
-
Conmed Corporation
-
B. Braun SE
-
Johnson and Johnson
*Disclaimer: Major Players sorted in no particular order
North America Bariatric Surgery Market News
- August 2022: Teleflex Incorporated entered into a definitive agreement to acquire Standard Bariatrics, Inc., which has commercialized an innovative powered stapling technology for bariatric surgery.
- July 2022: Apollo Endosurgery, Inc received the marketing authorization of the Apollo ESG TM, Apollo ESG Sx TM, Apollo REVISE TM, and Apollo REVISE Sx TM Systems through the United States FDA de novo classification process. These are the only devices authorized by the FDA for endoscopic sleeve gastroplasty (ESG) and endoscopic bariatric revision.
North America Bariatric Surgery Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increase in Obesity Patients
- 4.2.2 High Prevalence of Type-2 Diabetes and Heart Diseases
- 4.2.3 Increasing Public Awareness About Bariatric Surgery and Government Initiatives to Curb Obesity
-
4.3 Market Restraints
- 4.3.1 High Cost of Surgery
-
4.4 Porter Five Forces
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - in USD Millions)
-
5.1 By Device
- 5.1.1 Assisting Devices
- 5.1.1.1 Suturing Device
- 5.1.1.2 Closure Device
- 5.1.1.3 Stapling Device
- 5.1.1.4 Trocars
- 5.1.1.5 Other Assisting Devices
- 5.1.2 Implantable Devices
- 5.1.2.1 Gastric Bands
- 5.1.2.2 Electrical Stimulation Devices
- 5.1.2.3 Gastric Balloons
- 5.1.2.4 Gastric Emptying
- 5.1.3 Other Devices
-
5.2 Geography
- 5.2.1 United States
- 5.2.2 Canada
- 5.2.3 Mexico
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Medtronic PLC
- 6.1.2 Johnson and Johnson
- 6.1.3 Apollo Endosurgery Inc.
- 6.1.4 Intuitive Surgical Inc.
- 6.1.5 B. Braun SE
- 6.1.6 Olympus Corporation
- 6.1.7 CooperSurgical Inc.
- 6.1.8 Teleflex Incorporated (Standard Bariatrics Inc.)
- 6.1.9 Spatz Medical
- 6.1.10 Conmed Corporation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityNorth America Bariatric Surgery Industry Segmentation
As per the scope of the report, bariatric surgery or weight loss surgery is used as one of the major treatment procedures for treating obesity. It is generally the last option for patients who have failed in an attempt to lose weight by several other means. During this procedure, the size of the stomach is reduced by either removing some parts of the stomach or using a gastric band. The North America Bariatric Surgery Market is segmented by Device (Assisting Devices, Suturing Devices, Closure Devices, Stapling Devices, Trocars, and Other Assisting Devices), Implantable Devices (Gastric Bands, Electrical Stimulation Devices, Gastric Balloons, and Gastric Emptying), and Other Devices), and Geography (United States, Canada, and Mexico). The report offers the value (in USD million) for the above segments.
| By Device | Assisting Devices | Suturing Device |
| Closure Device | ||
| Stapling Device | ||
| Trocars | ||
| Other Assisting Devices | ||
| By Device | Implantable Devices | Gastric Bands |
| Electrical Stimulation Devices | ||
| Gastric Balloons | ||
| Gastric Emptying | ||
| By Device | Other Devices | |
| Geography | United States | |
| Canada | ||
| Mexico |
North America Bariatric Surgery Market Research FAQs
How big is the North America Bariatric Surgery Market?
The North America Bariatric Surgery Market size is expected to reach USD 1.05 billion in 2024 and grow at a CAGR of 5.45% to reach USD 1.38 billion by 2029.
What is the current North America Bariatric Surgery Market size?
In 2024, the North America Bariatric Surgery Market size is expected to reach USD 1.05 billion.
Who are the key players in North America Bariatric Surgery Market?
Medtronic PLC, Olympus Corporation, Conmed Corporation, B. Braun SE and Johnson and Johnson are the major companies operating in the North America Bariatric Surgery Market.
What years does this North America Bariatric Surgery Market cover, and what was the market size in 2023?
In 2023, the North America Bariatric Surgery Market size was estimated at USD 1 billion. The report covers the North America Bariatric Surgery Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Bariatric Surgery Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
North America Bariatric Surgery Industry Report
Statistics for the 2024 North America Bariatric Surgery market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Bariatric Surgery analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
